Abstract
Microtubules (MTs), which are highly dynamic assemblies of the protein tubulin, play important and diverse roles in eukaryotic cells. MT dynamics are regulated during the cell cycle by interacting with a large number of endogenous cellular regulators. In addition, many anti-tumour drugs and natural ligands that interact directly with tubulin are able to either stabilise or destabilise MTs and to disrupt the normal dynamics. Herein, we compare the structures of tubulin when complexed with different ligands in order to analyse: (i) various binding-sites of the protein and different positions of ligands within the microtubule (ii) the diverse effect on the microtubule dynamics. The structures and data given are essential for understanding tubulin-ligand interactions and their influence on the regulation of the microtubule system.
Keywords: Microtubules, microtubule-stabilising agent, structure based drug design, structure-activity relationship, tubulin, plus-end tracking proteins, Guanosine-5'-triphosphate, microtubule-associated proteins, microtubule-stabilising agent, microtubules, structure-activity relationship, stathmine-like domain, The tight complex tubulin/RB3-SLD
Current Cancer Drug Targets
Title:Structural Comparison of the Interaction of Tubulin with Various Ligands Affecting Microtubule Dynamics
Volume: 12 Issue: 6
Author(s): E. Stec-Martyna, M. Ponassi, M. Miele, S. Parodi, L. Felli and C. Rosano
Affiliation:
Keywords: Microtubules, microtubule-stabilising agent, structure based drug design, structure-activity relationship, tubulin, plus-end tracking proteins, Guanosine-5'-triphosphate, microtubule-associated proteins, microtubule-stabilising agent, microtubules, structure-activity relationship, stathmine-like domain, The tight complex tubulin/RB3-SLD
Abstract: Microtubules (MTs), which are highly dynamic assemblies of the protein tubulin, play important and diverse roles in eukaryotic cells. MT dynamics are regulated during the cell cycle by interacting with a large number of endogenous cellular regulators. In addition, many anti-tumour drugs and natural ligands that interact directly with tubulin are able to either stabilise or destabilise MTs and to disrupt the normal dynamics. Herein, we compare the structures of tubulin when complexed with different ligands in order to analyse: (i) various binding-sites of the protein and different positions of ligands within the microtubule (ii) the diverse effect on the microtubule dynamics. The structures and data given are essential for understanding tubulin-ligand interactions and their influence on the regulation of the microtubule system.
Export Options
About this article
Cite this article as:
Stec-Martyna E., Ponassi M., Miele M., Parodi S., Felli L. and Rosano C., Structural Comparison of the Interaction of Tubulin with Various Ligands Affecting Microtubule Dynamics, Current Cancer Drug Targets 2012; 12 (6) . https://dx.doi.org/10.2174/156800912801784893
DOI https://dx.doi.org/10.2174/156800912801784893 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular and Genetic Bases of Pancreatic Cancer
Current Drug Targets Genetic and Environmental Influences on Therapeutic and Toxicity Outcomes: Studies with CYP2A6
Current Clinical Pharmacology Phosphorylation-Specific Prolyl Isomerase Pin1 as a new Diagnostic and Therapeutic Target for Cancer
Current Cancer Drug Targets Metabolism of the Novel IMP Dehydrogenase Inhibitor Benzamide Riboside
Current Medicinal Chemistry Editorial (Thematic Issue: Investigate the Functions of Chemicals Through Heterogeneous Network of Chemicals and Proteins)
Combinatorial Chemistry & High Throughput Screening Drug Resistance in Renal Tumors of Childhood
Current Pharmaceutical Biotechnology Development of Drug Targeting and Delivery in Cervical Cancer
Current Cancer Drug Targets Synthesis and Anti Lung Cancer Activity of 3-Arylspiro[oxirane-2,3'- thiochroman]-4'-one Derivatives
Letters in Organic Chemistry Use of Biochemical and Microscopic Techniques to Determine Enhanced Skin Permeation of Nanovesicles: A Mechanistic Study
Pharmaceutical Nanotechnology Beyond Photodynamic Therapy: Light-Activated Cancer Chemotherapy
Current Medicinal Chemistry Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Extracellular Matrix and Aberrant Signaling in Lung Carcinoma: Role of Fibronectin in the Control of Human Lung Carcinoma Cell Growth,Apoptosis and Resistance to Therapy
Current Signal Transduction Therapy Key Roles of MicroRNA-22 Family in Complex Organisms Inferred from its Evolution
MicroRNA Surface Modified Nanoparticulate Carrier Constructs for Oral Mucosal Vaccine Delivery
Current Drug Delivery Structural Basis and Therapeutic Implication of the Interaction of CCN Proteins with Glycoconjugates
Current Pharmaceutical Design Dietary Fish Oil Reduces Colon Cancer Risk
Current Organic Chemistry The Psychiatric Drug Lithium Increases DNA Damage and Decreases Cell Survival in MCF-7 and MDA-MB-231 Breast Cancer Cell Lines Expos ed to Ionizing Radiation
Current Molecular Pharmacology Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs
Current Medicinal Chemistry Physiological Functions of Heat Shock Proteins
Current Protein & Peptide Science Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria
Current Drug Targets